
J&J COVID-19 vaccine benefits ‘far outweigh’ risks, CDC panel says after reports of Guillain-Barré syndrome
Fox News
An advisory panel to the Centers for Disease Control and Prevention (CDC) said the benefits of COVID-19 vaccines “far outweigh” potential risks amid an ongoing review of reports of a rare nerve disorder in a small fraction of J&J jab recipients.
Dr. Nicola Klein with the Kaiser Permanente Vaccine Study Center noted eight confirmed cases of GBS following J&J vaccination amid a backdrop of over 345,000 doses administered, per data collected through the Vaccine Safety Datalink. Nearly all confirmed cases occurred within 21 days of vaccination and involved adults aged 18-64. Researchers noted a reporting rate of 8.1 GBS cases per million J&J doses administered, versus 1.1 such cases following mRNA vaccination, compared to approximately 1.6 expected cases of GBS per million doses administered, per data collected through a national surveillance system, VAERS.More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












